Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Next NR

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Nov 21, 2024 6:50pm

167 Views

Post# 36324973

RE:RE:Next NR

All the good discussion about the bladder study makes me want to iterate that TLT is not a one drug and one indication company.

IV Ruvidar (Rutherrin) shows great promise for solid and liquid tumours
Ruvidar has antiviral properties that are potent and only just starting to be understood
Ruvidar may have a role in vaccine development (Manitoba work ongoing)

Those multiple avenues are a nice way of de-risking things.

I look forward to good updates in the coming 1-2 months.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale